inclusion criteria: 1. male and female patients aged 18-75 years old. 2. diagnosis of new coronavirus infection covid-19 based on medical examination: axillary temperature \>37.5°c, upper respiratory infection symptoms, spo2 ≥ 95%, no symptoms of moderate or severe forms. 3. the minimal baseline score for covid-19-related symptoms defined as follows: at least two symptoms with a score of 2 or higher, with the exception of taste and smell where subjects may have a score of 1 or higher, and the absence of shortness of breath (difficulty breathing). 4. positive rapid test for for sars-cov-2 (covid-19). 5. the first 24 hours from the disease onset. 6. patients giving their consent to use reliable contraception during the study. 7. signed patient information sheet (informed consent form).

inclusion criteria: 1. male and female patients aged 18-75 years old. 2. diagnosis of new coronavirus infection covid-19 based on medical examination: axillary temperature \>37.5°c, upper respiratory infection symptoms, spo2 ≥ 95%, no symptoms of moderate or severe forms. 3. the minimal baseline score for covid-19-related symptoms defined as follows: at least two symptoms with a score of 2 or higher, with the exception of taste and smell where subjects may have a score of 1 or higher, and the absence of shortness of breath (difficulty breathing). 4. positive rapid test for for sars-cov-2 (covid-19). 5. the first 24 hours from the disease onset. 6. patients giving their consent to use reliable contraception during the study. 7. signed patient information sheet (informed consent form).

inclusion criteria: male and female patients aged 18-75 years old. diagnosis of new coronavirus infection covid-19 based on medical examination: axillary temperature >37.5°c, upper respiratory infection symptoms, spo2 ≥ 95%, no symptoms of moderate or severe forms. the minimal baseline score for covid-19-related symptoms defined as follows: at least two symptoms with a score of 2 or higher, with the exception of taste and smell where subjects may have a score of 1 or higher, and the absence of shortness of breath (difficulty breathing). positive rapid test for for sars-cov-2 (covid-19). the first 24 hours from the disease onset. patients giving their consent to use reliable contraception during the study. signed patient information sheet (informed consent form).

inclusion criteria: male and female patients aged 18-75 years old. diagnosis of new coronavirus infection covid-19 based on medical examination: axillary temperature >37.5°c, upper respiratory infection symptoms, spo2 ≥ 95%, no symptoms of moderate or severe forms. the minimal baseline score for covid-19-related symptoms defined as follows: at least two symptoms with a score of 2 or higher, with the exception of taste and smell where subjects may have a score of 1 or higher, and the absence of shortness of breath (difficulty breathing). positive rapid test for for sars-cov-2 (covid-19). the first 24 hours from the disease onset. patients giving their consent to use reliable contraception during the study. signed patient information sheet (informed consent form).